Intelligent Bio Solutions (INBS) EBIT (2019 - 2025)

Intelligent Bio Solutions has reported EBIT for 7 years, with the latest figure at -$2.6 million in Q1 2025.

• For the quarter ending Q1 2025, EBIT rose 13.32% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2025 stood at -$10.4 million (down 1.85% YoY), and the FY2024 full-year result was -$10.3 million, up 18.36% from the prior year.
• EBIT for Q1 2025 stood at -$2.6 million, down from -$2.3 million in the prior quarter.
• The five-year high for EBIT was -$852646.0 in Q2 2021, with the low at -$6.5 million in Q1 2023.
• Average EBIT over 5 years is -$2.5 million, with a median of -$2.5 million recorded in 2023.
• Year-over-year, EBIT sank 10795.49% in 2021 and surged 57.24% in 2022.
• Tracing INBS's EBIT over 5 years: stood at -$3.5 million in 2021, then surged by 38.53% to -$2.1 million in 2022, then climbed by 6.55% to -$2.0 million in 2023, then dropped by 13.72% to -$2.3 million in 2024, then fell by 13.06% to -$2.6 million in 2025.
• The last three EBIT figures came in at -$2.6 million (Q1 2025), -$2.3 million (Q4 2024), and -$2.7 million (Q3 2024), per Business Quant data.

Peer Comparison